Dr (PhD) Gunnar Gottschalk

Dr Gunnar Gottschalk serves as Chief Executive Office (CEO) and Section Chief of Translational Science at Simmaron Research since 2020, a US-based organisation founded in 2011. The organisation is dedicated to the study of ME/CFS and related neuroimmune disorders. Dr Gottschalk was the lead research coordinator for Sierra Internal Medicine and was responsible for the execution of several large multi-centered investigations in ME/CFS. During the COVID-19 pandemic, he led a regional testing programme and established the Simmaron COVID-19 Biobank, enabling the initiation of several related research projects. His work focuses on elucidating molecular mechanisms, particularly in the areas of autophagy, immune regulation, and energy metabolism. A key focus of his research is the investigation of Rapamycin as a potential therapeutic approach, analysing how modulation of cellular signaling pathways may help improve symptoms in ME/CFS and Long COVID. Dr. Gottschalk is also an adjunct professor for Chemistry and Biochemistry at the University of Wisconsin–Milwaukee, US.